|
Form Serial Number: |
DA20211229E00175
|
1.
Date of relevant event: |
27/12/2021 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
27/12/2021 (dd/mm/yyyy)
|
3.
Stock code: |
01877 |
4.
Name of listed corporation: |
Shanghai Junshi Biosciences Co., Ltd. - H Shares |
5.
Class of shares: |
A Shares |
6.
Number of issued shares in class: |
691,461,000 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Xiong |
(Other names) |
Jun |
|
|
|
10.
Name of director (Chinese): |
熊俊 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1101 | The number of shares in which you are interested has increased because: you purchased the shares | |
|
|
152,000 |
CNY |
|
58.1100 |
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 218,390,986 | 31.58 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 218,542,986 | 31.60 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2201 | Interest of corporation controlled by you |
| |
2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2021 | 15/11/2022 | | | | | | | 328,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2022 | 15/11/2023 | | | | | | | 246,000 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2023 | 15/11/2024 | | | | | | | 246,000 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
深圳前海源本股权投资基金管理有限公司 | 深圳市前海深港合作区前湾一路鲤鱼门街1号前海深港合作管理局综合办公楼A栋201室 | Xiong Jun | 40.00 | N | |
苏州本裕天源生物科技合伙企业(有限合伙) | 苏州工业园区唯正路8号 | 深圳前海源本股权投资基金管理有限公司 | 86.28 | Y | |
苏州本裕天源生物科技合伙企业(有限合伙) | 苏州工业园区唯正路8号 | 深圳前海源本股权投资基金管理有限公司 | 86.28 | N | |
苏州瑞源盛本生物医药管理合伙企业(有限合伙) | 苏州市吴江区松陵镇开发区云黎路北侧 | 深圳前海源本股权投资基金管理有限公司 | 39.52 | Y | |
苏州瑞源盛本生物医药管理合伙企业(有限合伙) | 苏州市吴江区松陵镇开发区云黎路北侧 | 深圳前海源本股权投资基金管理有限公司 | 39.52 | N | |
上海宝盈资产管理有限公司 | 上海浦东新区花园石桥路33号703室710-712单元 | Xiong Jun | 20.00 | Y | |
上海宝盈资产管理有限公司 | 上海浦东新区花园石桥路33号703室710-712单元 | Xiong Jun | 20.00 | N | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Box 27: Xiong Jun is a party to concert party agreements dated 25 December 2017 and 26 July 2019, hence deemed to be interested in the Shares held by the other concert parties. Box 28: Restricted shares granted pursuant to the Company's 2020 Restricted A Share Incentive Scheme at the grant price of RMB55.50 per A Share. A grantee who has satisfied the relevant conditions may purchase new A Shares of the Company at such price. See the Company's circular dated 22 October 2020 for further details.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
29/12/2021 (dd/mm/yyyy)
|
|